Mark F. Indzonka, MD

Cardiovascular Disease (cardiology) in Stroudsburg, PA

1655 W Main St, Stroudsburg, PA 18360 · LVPG Internal Medicine - Bartonsville
NPI 1912911405 Accepts Medicare assignment Offers telehealth 40 years since graduation Public record — not managed by the clinician

About Dr. Mark Indzonka

Dr. Mark Indzonka is a physician specializing in cardiovascular disease (cardiology) practicing in Stroudsburg, PA, a graduate of State University of New York Downstate Medical Center (1986). Records list 6 practice addresses. Affiliated with Lehigh Valley Hospital, Lehigh Valley Hospital - Pocono, St Luke's Hospital - Monroe Campus and 1 more. Treated 1,200 Medicare patients in 2024.

SpecialtyCardiovascular Disease (cardiology)Other cardiovascular disease (cardiology) doctors in Stroudsburg
CredentialsMD
EducationState University of New York Downstate Medical Center, 1986CMS Doctors and Clinicians
GenderMale
NPI number1912911405National Provider Identifier (CMS NPPES), issued July 2006
MedicareEnrolled in Medicare; accepts Medicare assignment (the Medicare-approved amount as full payment)CMS Doctors and Clinicians
TelehealthOffers telehealth servicesCMS Doctors and Clinicians

Where Dr. Mark Indzonka practices

Addresses from CMS Doctors and Clinicians (Medicare enrollment). Call before visiting: a clinician may not see patients at every listed address.

Dr. Mark Indzonka's specialties and state licenses

Specialty (NPPES)License
Cardiovascular Disease PrimaryPA MD043750E

As reported by the clinician to the NPPES registry. Confirm a license and any disciplinary history with the state medical or licensing board.

Hospital affiliations of Dr. Mark Indzonka

  • Lehigh Valley HospitalHospital · Allentown, PA
  • Lehigh Valley Hospital - PoconoHospital · East Stroudsburg, PA
  • St Luke's Hospital - Monroe CampusHospital · Stroudsburg, PA
  • St Luke's Hospital BethlehemHospital · Bethlehem, PA

CMS Facility Affiliation data: facilities where the clinician bills Medicare.

Dr. Mark Indzonka's Medicare patients and services (2024)

1,200Medicare patients
3,005services billed
74average patient age
48%women

Most frequent services

ServiceTimesAvg. Medicare allowed
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only961$7.58
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more632$84.75
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more296$123.98
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function212$150.85
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes164$77.17
Anticoagulant management of patient taking warfarin121$11.09
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more85$162.06
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report71$13.83

Common conditions among these patients

  • High cholesterol75%
  • High blood pressure75%
  • Arthritis52%
  • Ischemic heart disease44%
  • Diabetes38%
  • Chronic kidney disease35%

Medicare Part B fee-for-service claims only (CMS Medicare Physician & Other Practitioners, 2024). Patients with private insurance or Medicare Advantage are not counted; small counts are suppressed by CMS. This describes the patients, not the quality of care.

Dr. Mark Indzonka's Medicare quality score (MIPS 2024)

100/100final MIPS score
100quality
40improvement activities

The Merit-based Incentive Payment System scores clinicians who bill Medicare. Reported as individual. Source: CMS Care Compare, PY 2024 clinician public reporting.

Payments from drug and device companies to Dr. Mark Indzonka (2025)

$1,599.43 in 69 general payments reported in 2025.

TypePaymentsAmount
Food and beverage69$1,599.43

Paying companies: scPharmaceuticals Inc. ($221.23), Boehringer Ingelheim Pharmaceuticals, Inc. ($216.55), Amgen Inc. ($188.64), Merck Sharp & Dohme LLC ($186.15), Pfizer Inc. ($182.17), E.R. Squibb & Sons, L.L.C. ($158.89).

Reported by companies under the federal Open Payments program (CMS, program year 2025). A payment, such as a meal at an educational event, does not mean wrongdoing; clinicians can dispute records with CMS.

Questions about Dr. Mark Indzonka

What kind of clinician is Dr. Mark Indzonka?

Dr. Mark Indzonka is listed as a physician specializing in cardiovascular disease (cardiology).

Where does Dr. Mark Indzonka practice?

LVPG Internal Medicine - Bartonsville at 1655 W Main St, Stroudsburg, PA 18360, and 5 other addresses in the records.

What is the office phone number for Dr. Mark Indzonka?

The listed office number is (570) 421-3800. Call to confirm availability and whether new patients are accepted.

What is the NPI number of Dr. Mark Indzonka?

The National Provider Identifier is 1912911405.

Does Dr. Mark Indzonka accept Medicare?

Yes. CMS lists this clinician as accepting Medicare assignment. Confirm your plan with the office.

Which hospitals is Dr. Mark Indzonka affiliated with?

Lehigh Valley Hospital, Lehigh Valley Hospital - Pocono, St Luke's Hospital - Monroe Campus, St Luke's Hospital Bethlehem.

Where did Dr. Mark Indzonka go to medical school?

State University of New York Downstate Medical Center, graduating in 1986.

Where this information comes from

CMS Doctors and CliniciansName, specialty, education, Medicare enrollment and practice addresses.Centers for Medicare & Medicaid Services, national downloadable file (2026)
NPPES NPI registryNPI, specialties (taxonomy) and state licenses.CMS National Plan and Provider Enumeration System; record updated 2011-02-01
Facility affiliationsHospitals and other facilities.CMS Doctors and Clinicians facility affiliation file; names from CMS Provider of Services
Medicare utilizationPatients, services and conditions.CMS Medicare Physician & Other Practitioners, 2024
MIPSQuality payment program scores.CMS clinician public reporting, PY 2024
Open PaymentsPayments from drug and device companies.CMS Open Payments, program year 2025

Information is public record and may lag behind changes. Clinicians update it through NPPES and Medicare PECOS. See something wrong? Tell us.

0 clinics selected Compare